Tokyo, Japan

Ippei Shimizu


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1983-2006

Loading Chart...
8 patents (USPTO):

Title: The Innovations of Ippei Shimizu

Introduction

Ippei Shimizu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical compositions, particularly in the area of blood lipid amelioration. With a total of 8 patents to his name, Shimizu's work has garnered attention for its potential health benefits.

Latest Patents

Shimizu's latest patents include a blood lipid ameliorant composition that contains atorvastatin in combination with various agents such as a riboflavin derivative, a tocopherol compound, an ascorbic acid derivative, pantethine, and taurine. Another significant patent features a blood lipid ameliorant composition containing simvastatin along with ingredients selected from a riboflavin compound, a d-α-tocopherol compound, an ascorbic acid compound, pantethine, and taurine. These innovations highlight his commitment to improving health outcomes through scientific research.

Career Highlights

Throughout his career, Shimizu has worked with prominent companies such as Sankyo Company, Limited and Jujo Paper Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.

Collaborations

Some of Shimizu's notable coworkers include Tsuneki Ohsawa and Ikuo Takagi. Their collaborative efforts have likely played a role in the successful development of his patented innovations.

Conclusion

Ippei Shimizu's contributions to the field of medical compositions demonstrate his innovative spirit and dedication to improving health. His patents reflect a deep understanding of biochemistry and a commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…